Fig. 5
From: Cost-effectiveness of dexamethasone compared with aflibercept in naïve diabetic macular edema
Cost-effectiveness scatterplot for dexamethasone generated by MonteCarlo simulation. In quadrant I 47% of cases resulted, which means that the greater the cost, the greater the quality of life obtained. In quadrant II it is showed that in 8% of cases, the higher the cost, the fewer QALYs are obtained. In quadrant III 36% of cases resulted, which means that the fewer the cost, the fewer the quality of life obtained and 9% of cases resulted in quadrant IV, which means that the fewer the cost, the greater QALYs are obtained